- Home
- BLCO vs ELAN Comparison
BLCO vs ELAN Comparison
Compare BLCO & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- ELAN
- Stock Information
- Founded
- BLCO 1853
- ELAN 1954
- Country
- BLCO Canada
- ELAN United States
- Employees
- BLCO N/A
- ELAN N/A
- Industry
- BLCO Ophthalmic Goods
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- BLCO Health Care
- ELAN Health Care
- Exchange
- BLCO Nasdaq
- ELAN Nasdaq
- Market Cap
- BLCO 5.6B
- ELAN 5.4B
- IPO Year
- BLCO 2022
- ELAN 2018
- Fundamental
- Price
- BLCO $14.14
- ELAN $10.42
- Analyst Decision
- BLCO Hold
- ELAN Buy
- Analyst Count
- BLCO 11
- ELAN 6
- Target Price
- BLCO $19.10
- ELAN $15.00
- AVG Volume (30 Days)
- BLCO 578.8K
- ELAN 3.8M
- Earning Date
- BLCO 04-30-2025
- ELAN 05-07-2025
- Dividend Yield
- BLCO N/A
- ELAN N/A
- EPS Growth
- BLCO N/A
- ELAN N/A
- EPS
- BLCO N/A
- ELAN 0.68
- Revenue
- BLCO $4,791,000,000.00
- ELAN $4,439,000,000.00
- Revenue This Year
- BLCO $6.53
- ELAN $3.20
- Revenue Next Year
- BLCO $5.64
- ELAN $4.26
- P/E Ratio
- BLCO N/A
- ELAN $15.12
- Revenue Growth
- BLCO 15.56
- ELAN 0.50
- 52 Week Low
- BLCO $13.16
- ELAN $10.03
- 52 Week High
- BLCO $21.69
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- BLCO 26.70
- ELAN 42.62
- Support Level
- BLCO $15.23
- ELAN $10.45
- Resistance Level
- BLCO $15.77
- ELAN $10.85
- Average True Range (ATR)
- BLCO 0.44
- ELAN 0.36
- MACD
- BLCO -0.05
- ELAN 0.03
- Stochastic Oscillator
- BLCO 11.82
- ELAN 40.10
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.